|
|
Psychemedics Corporation (NASDAQ: PMD) |
|
Price: $2.6700
$-0.05 
-1.838%
|
| Day's High:
| $2.77
| Week Perf:
| -16.82 %
|
| Day's Low: |
$ 2.46 |
30 Day Perf: |
13.86 % |
| Volume (M): |
112 |
52 Wk High: |
$ 3.64 |
| Volume (M$): |
$ 300 |
52 Wk Avg: |
$2.54 |
| Open: |
$2.61 |
52 Wk Low: |
$1.63 |
|
|
| Market Capitalization (Millions $) |
16 |
| Shares
Outstanding (Millions) |
6 |
| Employees |
90 |
| Revenues (TTM) (Millions $) |
20 |
| Net Income (TTM) (Millions $) |
-3 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Psychemedics Corporation
Psychemedics Corp is a biotechnology company based in the United States. It specializes in the development and commercialization of tests that detect drug abuse and substances in hair samples. The company uses a patented technology called hair analysis to provide accurate and reliable results. This technology allows for a longer detection window compared to urine or blood tests and is considered more difficult to tamper with. Psychemedics Corp primarily serves employers, law enforcement agencies, and schools by providing drug testing services.
Company Address: 5220 Spring Valley Road Dallas 75254 TX
Company Phone Number: 527-7424 Stock Exchange / Ticker: NASDAQ PMD
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Shares
Published Mon, Dec 2 2024 1:10 PM UTC
On December 2, 2024, Psychemedics Corporation (Nasdaq: PMD), the leading provider of hair testing for drugs of abuse, announced a dual stock split aimed at restructuring its share capital. The plan includes a 1-for-5,000 reverse stock split followed immediately by a 5,000-for-1 forward stock split, effective at 5:01 p.m. and 5:02 p.m. Eastern Time on December 3, 2024, respec...
|
| Product Service News
Published Thu, Aug 29 2024 1:00 PM UTC
Psychemedics Corporation Unveils New Ketamine Hair Testing Service Amidst Market Performance Challenges Psychemedics Corporation, a pioneering figure in drug testing technology, has taken a significant leap forward with the announcement of their latest innovation: a state-of-the-art ketamine hair testing service. This cutting-edge solution underscores Psychemedics unwaverin...
|
| Psychemedics Corporation
Psychemedics Corporation, a leading provider of hair testing for drugs of abuse, recently announced its financial results for the first quarter of 2024. While the earnings season witnessed a widening of diminishing returns, income per share improved compared to the preceding quarter. Despite a decrease in revenue during the quarter, the company's decision to relocate its corporate headquarters to Dallas, Texas, unveils a strategic move to solidify its position as a global leader in the industry. This article will explore the potential impact of this relocation and its implications for Psychemedics Corporation's future.
Diminishing Returns and Improved Income per Share:
In the first quarter of 2024, Psychemedics Corporation experienced a widening of diminishing returns, with a per-share decrease of $0.12 compared to the previous year's $0.07. However, it is noteworthy that income per share improved from the preceding quarter, signaling progress in the company's financial performance. This positive trend indicates that Psychemedics Corporation's efforts to enhance operational efficiency and streamline its financial structure are proving fruitful.
|
| Psychemedics Corporation
The stock market is an ever-changing landscape, influenced by a myriad of factors including financial performance, strategic decisions, and market conditions. One company that recently made headlines in the stock market is Psychemedics Corporation (NASDAQ: PMD), a leading provider of hair testing for drugs of abuse. They announced their financial results for the year ended December 31, 2023, revealing some interesting facts.
One of the standout figures from their fiscal report is the widening of their PMD Deficit. For the fiscal span ending December 31, 2023, the deficit increased to $-0.13 per share, compared to $-0.08 the previous year. On a positive note, the company's EPS (Earnings Per Share) improved from $-0.36 per share in the previous reporting period.
|
| Product Service News
Published Tue, Jan 2 2024 4:28 PM UTC
In a strategic move, Psychemedics Corporation, a frontrunner in the field of hair testing for drugs of abuse, has announced the relocation of its corporate headquarters to Dallas, Texas. This significant decision is set to solidify Psychemedics Corporation s position as a global leader in the industry, benefiting both the company and its clients. In this article, we will del...
|
| Per Share |
Current |
| Earnings (TTM) |
-0.48 $ |
| Revenues (TTM) |
3.41 $
|
| Cash Flow (TTM) |
0.01 $ |
| Cash |
0.24 $
|
| Book Value |
0.92 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.48 $
|
| Revenues (TTM) |
3.41 $ |
| Cash Flow (TTM) |
0.01 $ |
| Cash |
0.24 $
|
| Book Value |
0.92 $ |
| Dividend (TTM) |
0 $ |
|
|
|
|
